MENU
+Compare
CLYYF
Stock ticker: OTC
AS OF
Aug 12 closing price
Price
$0.41
Change
-$0.12 (-22.64%)
Capitalization
17.52M

CLYYF Celyad Oncology SA Forecast, Technical & Fundamental Analysis

Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of technologies for chimeric antigen receptor T-cell (CAR T) therapies... Show more

CLYYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CLYYF with price predictions
Aug 29, 2025

CLYYF's RSI Oscillator is remaining in oversold zone for 13 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on August 26, 2025. You may want to consider a long position or call options on CLYYF as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CLYYF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CLYYF turned negative on August 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 12 similar instances when the indicator turned negative. In of the 12 cases the stock turned lower in the days that followed. This puts the odds of success at .

CLYYF moved below its 50-day moving average on August 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CLYYF crossed bearishly below the 50-day moving average on August 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CLYYF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.456) is normal, around the industry mean (19.821). P/E Ratio (0.000) is within average values for comparable stocks, (52.034). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.591). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (357.143) is also within normal values, averaging (302.560).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLYYF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CLYYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Rue Edouard Belin 2
Phone
+32 10394100
Employees
39
Web
https://www.celyad.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRHYY0.250.01
+5.93%
Syrah Resources Ltd.
FCUL0.08N/A
N/A
Food Culture Inc.
UNEH1.50N/A
N/A
Universal New Energy Holding Group, Inc.
AKZOY23.13-0.01
-0.02%
Akzo Nobel N.V.
BCAUF0.52-0.03
-4.85%
Brilliance China Automotive Holding Ltd.

CLYYF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYYF has been loosely correlated with ELVAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYYF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYYF
1D Price
Change %
CLYYF100%
N/A
ELVAF - CLYYF
47%
Loosely correlated
N/A
WHWK - CLYYF
37%
Loosely correlated
+1.98%
HLVX - CLYYF
26%
Poorly correlated
+0.48%
REPL - CLYYF
25%
Poorly correlated
+0.37%
WXXWY - CLYYF
25%
Poorly correlated
+8.25%
More